Alzamend Neuro Inc. (ALZN)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
1. 28
-0.07
-5.1852%
Pre Market
$
+0.21 +16.4062% 1. 49
5.1M Market Cap
- P/E Ratio
- Div Yield
14,799 Volume
- Eps
$ 1.35
Previous Close Investors:
Want to track ALZN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alzamend Neuro (ALZN) Upgraded to Buy: What Does It Mean for the Stock?
Alzamend Neuro (ALZN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 1 week ago
Alzamend Neuro (ALZN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
After losing some value lately, a hammer chart pattern has been formed for Alzamend Neuro (ALZN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks | 1 year ago
Has Alzamend Neuro (ALZN) Outpaced Other Medical Stocks This Year?
Here is how Alzamend Neuro, Inc. (ALZN) and Beam Therapeutics Inc. (BEAM) have performed compared to their sector so far this year.
Zacks | 1 year ago
Alzamend Neuro Stock Jumps After Post Traumatic Stress Disorder Study Pact: Details
Monday, Alzamend Neuro Inc. ALZN stock is trading higher after the company partnered with Massachusetts General Hospital as its contract research organization.
Benzinga | 2 years ago
2026 © Marketlog. All Rights Reserved.
